Total Payments
$41,183
2024 Payments
$2,657
Companies
53
Transactions
660
Medicare Patients
21,721
Medicare Billing
$2.7M
Payment Breakdown by Category
Other$16,250 (39.5%)
Food & Beverage$13,785 (33.5%)
Consulting$6,500 (15.8%)
Travel$4,450 (10.8%)
Research$134.85 (0.3%)
Education$62.58 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,785 | 627 | 33.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,250 | 5 | 32.2% |
| Consulting Fee | $6,500 | 1 | 15.8% |
| Travel and Lodging | $4,450 | 18 | 10.8% |
| Honoraria | $3,000 | 1 | 7.3% |
| Unspecified | $134.85 | 1 | 0.3% |
| Education | $62.58 | 7 | 0.2% |
Payments by Type
General
$41,048
659 transactions
Research
$134.85
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14,794 | 69 | $0 (2024) |
| Inari Medical, Inc. | $7,493 | 16 | $0 (2024) |
| ABIOMED | $5,500 | 43 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,984 | 22 | $0 (2024) |
| Boston Scientific Corporation | $1,920 | 43 | $0 (2024) |
| Abbott Laboratories | $1,390 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,215 | 95 | $0 (2024) |
| Amgen Inc. | $1,192 | 79 | $0 (2024) |
| Baylis Medical Company Inc | $994.94 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $661.58 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,657 | 77 | Boston Scientific Corporation ($976.64) |
| 2023 | $1,340 | 54 | Edwards Lifesciences Corporation ($241.47) |
| 2022 | $3,416 | 99 | Edwards Lifesciences Corporation ($1,510) |
| 2021 | $1,679 | 106 | Janssen Pharmaceuticals, Inc ($421.97) |
| 2020 | $7,571 | 47 | Inari Medical, Inc. ($6,646) |
| 2019 | $6,559 | 77 | ABIOMED ($3,962) |
| 2018 | $2,013 | 94 | ABIOMED ($371.49) |
| 2017 | $15,947 | 106 | Novartis Pharmaceuticals Corporation ($13,967) |
All Payment Transactions
660 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: VTE | ||||||
| 12/20/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $171.26 | General |
| Category: VTE | ||||||
| 12/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $180.63 | General |
| Category: Heart Failure | ||||||
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Obesity | ||||||
| 11/20/2024 | CORDIS US CORP. | Mynx Venous VCD (Device) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $4.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: VTE | ||||||
| 11/08/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $46.35 | General |
| Category: VTE | ||||||
| 09/26/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/25/2024 | Medtronic, Inc. | HAWKONE (Device) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Directional Atherectomy Devices | ||||||
| 09/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Heart Failure | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: ACCOLADE_CRM | ||||||
| 09/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $41.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| impella | ABIOMED | $134.85 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 4,693 | 8,119 | $1.3M | $593,561 |
| 2022 | 47 | 5,191 | 8,902 | $1.4M | $668,539 |
| 2021 | 49 | 5,471 | 9,543 | $1.5M | $756,474 |
| 2020 | 48 | 6,366 | 10,374 | $1.3M | $663,431 |
Total Patients
21,721
Total Services
36,938
Medicare Billing
$2.7M
Procedure Codes
197
All Medicare Procedures & Services
197 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 456 | 1,603 | $152,285 | $104,947 | 68.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 479 | 827 | $82,700 | $56,281 | 68.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 157 | 158 | $142,200 | $54,316 | 38.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 316 | 330 | $82,500 | $46,893 | 56.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 283 | 292 | $110,815 | $39,580 | 35.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 157 | 316 | $47,400 | $30,623 | 64.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 47 | 68 | $69,360 | $29,591 | 42.7% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 39 | 39 | $78,000 | $25,262 | 32.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 130 | 524 | $36,680 | $22,275 | 60.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 249 | $37,350 | $21,090 | 56.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 81 | 85 | $44,625 | $16,352 | 36.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 106 | 138 | $23,460 | $14,928 | 63.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 104 | 104 | $35,035 | $13,424 | 38.3% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 39 | 39 | $25,740 | $11,470 | 44.6% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 42 | 232 | $17,400 | $11,187 | 64.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 571 | 980 | $49,000 | $10,651 | 21.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 157 | 158 | $23,700 | $7,899 | 33.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 16 | 16 | $13,440 | $7,201 | 53.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $13,650 | $6,897 | 50.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 30 | 33 | $15,180 | $6,138 | 40.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 96 | 233 | $15,145 | $5,140 | 33.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 117 | 287 | $15,785 | $4,708 | 29.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 44 | 47 | $12,220 | $3,962 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 48 | $7,200 | $3,872 | 53.8% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $10,710 | $3,664 | 34.2% |
About Dr. Luay Sayed, MD
Dr. Luay Sayed, MD is a Cardiovascular Disease healthcare provider based in Shelby Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063414696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luay Sayed, MD has received a total of $41,183 in payments from pharmaceutical and medical device companies, with $2,657 received in 2024. These payments were reported across 660 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($13,785).
As a Medicare-enrolled provider, Sayed has provided services to 21,721 Medicare beneficiaries, totaling 36,938 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 197 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Shelby Township, MI
- Active Since 08/12/2005
- Last Updated 03/07/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063414696
Products in Payments
- ENTRESTO (Drug) $14,572
- FlowTriever (Device) $6,892
- Impella (Device) $5,500
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $1,494
- XARELTO (Drug) $1,255
- NRG needle (Device) $994.94
- Repatha (Biological) $732.61
- FLOWTRIEVER CATHETER, S (Device) $601.13
- PRALUENT (Drug) $562.50
- BRILINTA (Drug) $528.57
- Corlanor (Drug) $449.42
- Vascepa (Drug) $435.95
- ELIQUIS (Drug) $284.91
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $222.17
- LEQVIO (Drug) $221.55
- LifeVest (Device) $212.14
- WATCHMAN (Device) $195.62
- Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $188.42
- Accessories (Structural Intervention) (Device) $172.89
- EKOSONIC (Device) $165.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.